Skip to content
OpenCapital
Get started

Organon OGN EBITDA

EBITDA at other companies

Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$72.9M+51.6%
Pfizer logo
PfizerPFE
——
Amgen logo
AmgenAMGN
——
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
——
AbbVie logo
AbbVieABBV
——
Viatris logo
ViatrisVTRS
——

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%—
Debt / equity9.5×-7.0×
Current ratio2×+0.3×

Where this comes from

Calculated from Organon’s reported figures.

$324.0Mebit+
$39.0MDepreciation Depletion & Amortization
=$363M

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's EBITDA?
Organon (OGN) reported EBITDA of $363M in Q1 2026.
How has Organon's EBITDA changed year-over-year?
Organon's EBITDA increased by 40.2% year-over-year, from $259M to $363M.
What is the long-term trend for Organon's EBITDA?
Over 3 years (2021 to 2024), Organon's EBITDA has grown at a -8.1% compound annual growth rate (CAGR), from $1.88B to $1.46B.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.